SciBase Sees Increased Investment from Major Shareholders
SciBase, a leader in AI-based dermatology devices, has seen a significant increase in investment from its main shareholders. Announced in a press release, Ribbskottet AB and Life Science Investment Fund have each purchased approximately 7.5 million shares in a block trade. This transaction was conducted off the stock exchange from larger long-term owners.
Anders Bladh, CEO of Ribbskottet AB, expressed confidence in SciBase's growth and potential, citing the company's recent collaborations, including one with Castle Biosciences Inc. Jan Poulsen, CEO of Life Science Investment Fund, also highlighted the compelling investment opportunity presented by SciBase's current valuation.
SciBase specializes in early detection and prevention in dermatology, utilizing its Nevisense platform that combines AI and advanced EIS technology to enhance diagnostic accuracy. The company has been listed on the Nasdaq First North Growth Market since 2015.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
sci2sci Raises €1.2 Million for AI Verification Software
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
RiskScout Raises Funding for AI Compliance Platform
Sunthetics Joins $19.5M NSF Autonomous Lab Initiative
Daily AI Brief: the AI news that matters, in your inbox.